Particularly, U. Cucinotta et al. concluded that patients with VEO IBD may have a more severe disease course and a poorer response to steroids and anti-TNF-α agents, and they may require more frequent surgical treatment than P-IBD patients (30). This evidence concerns the gene TNF and inflammatory bowel disease.